Alliance Director. Each Party shall appoint one person to be its point of contact with responsibility for facilitating communication and collaboration between the Parties (each, an “Alliance Director”). The Alliance Directors shall be permanent participants of the JRC meetings (but not members of the JRC) and may attend JOT meetings as appropriate. The Alliance Directors shall facilitate resolution of potential and pending issues and potential disputes to enable the JRC to reach consensus and avert escalation of such issues or potential disputes.
Appears in 6 contracts
Samples: Collaboration and License Agreement (Monte Rosa Therapeutics, Inc.), Research Collaboration and License Agreement (HOOKIPA Pharma Inc.), License Agreement (Avista Public Acquisition Corp. II)
Alliance Director. Each Party shall appoint one (1) person to be its point of contact with responsibility for facilitating communication and collaboration between the Parties (each, an “Alliance Director”). The Alliance Directors shall be permanent participants of the JRC committee meetings (but not members Members of the JRCcommittees) and may attend JOT meetings as appropriate. The Alliance Directors shall facilitate resolution of potential and pending issues and potential disputes to enable the JRC committees to reach consensus and avert escalation of such issues or potential disputes.
Appears in 3 contracts
Samples: Collaboration and License Agreement (Blueprint Medicines Corp), Collaboration and License Agreement (Blueprint Medicines Corp), Collaboration and License Agreement (Blueprint Medicines Corp)
Alliance Director. Each Party shall appoint one person to be its the point of contact within each Party with responsibility for facilitating communication and collaboration between the Parties (each, an “Alliance Director”). The Alliance Directors shall be permanent participants of may participate in the JRC meetings (but not members of the JRC) and may attend JOT meetings as appropriatemeetings. The Alliance Directors shall facilitate resolution of potential and pending issues and potential disputes to enable the JRC to reach consensus and avert escalation of such issues or potential disputes.
Appears in 3 contracts
Samples: Research Collaboration and License Agreement (Pieris Pharmaceuticals, Inc.), Research Collaboration and License Agreement (Pieris Pharmaceuticals, Inc.), Research Collaboration and License Agreement (Pieris Pharmaceuticals, Inc.)
Alliance Director. Each Party shall appoint one person to be its the point of contact within each Party with responsibility for facilitating communication and collaboration between the Parties (each, an “Alliance Director”). The Alliance Directors shall be permanent participants of the JRC JMC meetings (but not members of the JRCJMC) and may attend JDRC, JOC and JOT meetings as appropriate. The Alliance Directors shall facilitate resolution of potential and pending issues and potential disputes to enable the JRC JMC to reach consensus and avert escalation of such issues or potential disputes.
Appears in 2 contracts
Samples: Collaboration Agreement (Foundation Medicine, Inc.), Collaboration Agreement (Foundation Medicine, Inc.)
Alliance Director. Each Party shall appoint one person to be its point of contact with responsibility for facilitating communication and collaboration between the Parties (each, an “Alliance Director”). The Alliance Directors shall be permanent participants of the JRC meetings (but not members of the JRC) and may attend JOT meetings as appropriate). The Alliance Directors shall facilitate resolution of potential and pending issues and potential disputes to enable the JRC to reach consensus and avert escalation of such issues or potential disputes.
Appears in 2 contracts
Samples: License Agreement (C4 Therapeutics, Inc.), License Agreement (C4 Therapeutics, Inc.)
Alliance Director. Each Party shall appoint one person to be its point of contact with responsibility for facilitating communication and collaboration between the Parties (each, an “Alliance Director”). The Alliance Directors shall be permanent participants of the JRC meetings (but not members of the JRC) and may attend JOT meetings as appropriatemeetings. The Alliance Directors shall facilitate resolution of potential and pending issues and potential disputes to enable the JRC to reach consensus and avert escalation of such issues or potential disputesdisputes and to implement the Agreement and any amendments thereto.
Appears in 2 contracts
Samples: Collaboration and License Agreement (C4 Therapeutics, Inc.), Collaboration and License Agreement (C4 Therapeutics, Inc.)
Alliance Director. Each Party shall appoint one person to be its point of contact with responsibility for facilitating communication and collaboration between the Parties (each, an “Alliance Director”). The Alliance Directors shall be permanent participants of at the JRC JSC meetings (but not members of the JRCmembers) and may attend JRDT and other JOT meetings meetings, and JCC meetings, as appropriate. The Alliance Directors shall facilitate resolution of potential and pending issues and potential disputes to enable the JRC JSC to reach consensus and avert escalation of such issues or potential disputes.
Appears in 1 contract
Samples: License and Collaboration Agreement (SQZ Biotechnologies Co)
Alliance Director. Each Party shall appoint one person to be its point of contact with responsibility for facilitating communication and collaboration between the Parties (each, an “Alliance Director”). The Alliance Directors shall be permanent participants of the JRC and JDC meetings (but not members of the JRCJRC and JDC) and may attend JOT meetings as appropriate. The Alliance Directors shall facilitate resolution of potential and pending issues and potential disputes to enable the JRC or JDC to reach consensus and avert escalation of such issues or potential disputes.
Appears in 1 contract
Samples: Collaboration, Option and License Agreement (Vividion Therapeutics, Inc.)
Alliance Director. Each Party shall appoint one person to be its point of contact with responsibility for facilitating communication and collaboration between the Parties (each, an “Alliance Director”). The Alliance Directors shall be permanent participants of the JRC JSC meetings (but not members of the JRC) and may attend JOT meetings as appropriate. The Alliance Directors shall facilitate resolution of potential and pending issues and potential disputes to enable the JRC JSC to reach consensus and avert escalation of such issues or potential disputes.
Appears in 1 contract
Samples: Collaboration and License Agreement (4D Molecular Therapeutics Inc.)